Journal of Clinical Oncology

Journal of Clinical Oncology is a peer-reviewed medical journal publishing research on clinical trials, translational studies, and practice-changing oncology findings from institutions such as Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Dana-Farber Cancer Institute, and MD Anderson Cancer Center. The journal is produced by the American Society of Clinical Oncology and has published influential reports involving investigators from National Cancer Institute, European Society for Medical Oncology, University of Oxford, Harvard Medical School, and Stanford University School of Medicine. Its articles often influence guidelines from organizations like National Comprehensive Cancer Network, European Medicines Agency, and U.S. Food and Drug Administration.

History

The journal was established in 1983 under the auspices of the American Society of Clinical Oncology and succeeded earlier specialty publications connected to clinical oncology programs at Roswell Park Comprehensive Cancer Center and Royal Marsden Hospital. Early editors collaborated with investigators at Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Chicago Medicine, and University of Pennsylvania Health System to publish randomized trials, cooperative group studies from the Children's Oncology Group, and multicenter efforts coordinated with the Cancer and Leukemia Group B. Landmark trials reported during the 1980s and 1990s involved cooperative groups such as Eastern Cooperative Oncology Group and Southwest Oncology Group and included contributors from Memorial Sloan Kettering Cancer Center, Mayo Clinic, and Massachusetts General Hospital. Across the 2000s and 2010s the journal expanded digital access alongside initiatives at National Institutes of Health, collaborations with European Organisation for Research and Treatment of Cancer, and partnerships with academic centers like Yale School of Medicine and Columbia University Irving Medical Center.

Scope and Content

The journal focuses on clinical oncology research including randomized controlled trials from groups such as SWOG, translational science linking laboratories at Cold Spring Harbor Laboratory and Broad Institute to clinical investigators at UCLA Health and Vanderbilt University Medical Center, and guideline-defining meta-analyses cited by World Health Organization cancer programs. Typical content includes reports on systemic therapies developed by pharmaceutical companies like Roche, Novartis, Merck & Co., and Bristol Myers Squibb; biomarker-driven studies involving teams from Scripps Research and Wellcome Sanger Institute; and survivorship research with contributors from University of Toronto and McGill University Health Centre. The journal routinely publishes clinical practice recommendations aligned with panels convened by American College of Physicians and consensus statements involving the American Society of Hematology and specialty societies such as Society of Surgical Oncology.

Editorial Board and Publication Practices

The editorial leadership has included editors affiliated with Columbia University, Weill Cornell Medicine, University of California, San Francisco, and University of Michigan. The board comprises clinicians and researchers from centers such as Princess Margaret Cancer Centre, Karolinska Institutet, Institut Gustave Roussy, Royal Marsden Hospital, and King's College London. Peer review processes involve external reviewers drawn from networks including European Society for Medical Oncology, American Association for Cancer Research, and advisory committees at National Cancer Institute. Publication practices emphasize randomized evidence similar to trials registered at ClinicalTrials.gov and protocols overseen by institutional review boards at Beth Israel Deaconess Medical Center and Cleveland Clinic, with ethical oversight referencing declarations from bodies like World Medical Association.

Abstracting and Indexing

Articles are indexed in major bibliographic services including Index Medicus, MEDLINE, PubMed, Scopus, and Web of Science. The journal's metadata are used by databases maintained by organizations such as National Library of Medicine, Clarivate, and Elsevier. Abstracting services and citation indexes that include the journal also inform impact calculations used by institutions such as University College London and funding bodies like National Institutes of Health and Wellcome Trust.

Impact and Reception

The journal has high citation metrics and has published practice-changing trials that influenced approvals by the U.S. Food and Drug Administration and guidelines from the National Comprehensive Cancer Network. Papers from authors at Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, and Johns Hopkins Hospital have been widely cited in policy documents by World Health Organization cancer programs and reviews by Lancet Oncology and New England Journal of Medicine. Reception among professional societies such as American Society of Clinical Oncology and European Society for Medical Oncology has been positive for methodological rigor, while occasional editorials and debates have involved contributors from Nature Medicine and JAMA Oncology.

Category:Oncology journals Category:Academic journals published by learned and professional societies